Virulence properties and protective efficacy of the capsular polymer of Haemophilus (Actinobacillus) pleuropneumoniae serotype 5
- PMID: 3397178
- PMCID: PMC259496
- DOI: 10.1128/iai.56.8.1880-1889.1988
Virulence properties and protective efficacy of the capsular polymer of Haemophilus (Actinobacillus) pleuropneumoniae serotype 5
Abstract
The role of the capsule of Haemophilus (Actinobacillus) pleuropneumoniae serotype 5 in bacterial virulence, and the protective efficacy of antibody to serotype 5 capsule was investigated. Encapsulated H. pleuropneumoniae serotype 5 were resistant to killing by complement and antibody to capsule or somatic antigens, whereas a noncapsulated mutant was sensitive to killing by the alternative complement pathway alone. Antiserum to whole H. pleuropneumoniae serotype 5 bacteria or monospecific antiserum to capsule was capable of opsonizing bacteria of the homologous serotype for phagocytosis by swine polymorphonuclear leukocytes but was not opsonic for a heterologous serotype. An immunoglobulin M monoclonal antibody to the serotype 5 capsule was not opsonic for any serotype. Mice were protected against lethal, intranasal challenge with the homologous or heterologous serotype after immunization with live encapsulated or noncapsulated bacteria, but not after immunization with killed bacteria, lipopolysaccharide, or a capsule-protein conjugate vaccine. The protection induced by immunization with live bacteria was transferred to nonimmune, syngeneic mice by serum but not by spleen cells. Nonimmune pigs passively immunized with monospecific swine serum to capsule were protected from lethal infection but not from development of hemorrhagic lung lesions, whereas pigs passively immunized with swine antiserum to live bacteria did not develop severe respiratory lesions. Thus, the capsule of H. pleuropneumoniae serotype 5 was inhibitory to the bactericidal activity of serum and was antiphagocytic. Antibody to the capsule was opsonic but was not fully protective.
Similar articles
-
Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines.Infect Immun. 1993 May;61(5):1682-6. doi: 10.1128/iai.61.5.1682-1686.1993. Infect Immun. 1993. PMID: 8478056 Free PMC article.
-
Serotype specificity and immunogenicity of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.Infect Immun. 1987 Jul;55(7):1580-7. doi: 10.1128/iai.55.7.1580-1587.1987. Infect Immun. 1987. PMID: 3110066 Free PMC article.
-
Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies and protects against homologous aerosol challenge.Infect Immun. 1995 Aug;63(8):3048-53. doi: 10.1128/iai.63.8.3048-3053.1995. Infect Immun. 1995. PMID: 7622229 Free PMC article.
-
Capsules and virulence in the HAP group of bacteria.Can J Vet Res. 1990 Apr;54 Suppl:S22-7. Can J Vet Res. 1990. PMID: 2193699 Review.
-
Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity.Anim Health Res Rev. 2000 Dec;1(2):73-93. doi: 10.1017/s1466252300000074. Anim Health Res Rev. 2000. PMID: 11708600 Review.
Cited by
-
Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.PLoS One. 2018 Jun 1;13(6):e0198207. doi: 10.1371/journal.pone.0198207. eCollection 2018. PLoS One. 2018. PMID: 29856812 Free PMC article.
-
Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines.Infect Immun. 1993 May;61(5):1682-6. doi: 10.1128/iai.61.5.1682-1686.1993. Infect Immun. 1993. PMID: 8478056 Free PMC article.
-
Modulation of gene expression in Actinobacillus pleuropneumoniae exposed to bronchoalveolar fluid.PLoS One. 2009 Jul 3;4(7):e6139. doi: 10.1371/journal.pone.0006139. PLoS One. 2009. PMID: 19578537 Free PMC article.
-
Simplified procedure for preparation of sensitized latex particles to detect capsular polysaccharides: application to typing and diagnosis of Actinobacillus pleuropneumoniae.J Clin Microbiol. 1995 Sep;33(9):2297-303. doi: 10.1128/jcm.33.9.2297-2303.1995. J Clin Microbiol. 1995. PMID: 7494018 Free PMC article.
-
Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host.Vet Res. 2010 Sep-Oct;41(5):65. doi: 10.1051/vetres/2010037. Epub 2010 Jun 15. Vet Res. 2010. PMID: 20546697 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources